Justin Loke

@jloke1.bsky.social

CRUK Manchester Institute Fellow/Group Leader Hon Con. Haematologist The Christie NHS Former AACR-CRUK Transatlantic Fellow Dana-Farber Cancer Institute https://www.cruk.manchester.ac.uk/team-member/justin-loke/

There's still time to apply to our #PhD Programme here in #Manchester Visit our website to see all the projects accepting applications, plus the support for students which includes: ⭐4 year fully funded PhD ⭐Tax-free stipend ⭐Support & mentorship ⭐Access to cutting-edge facilities and lab spaces

PhD Student Recruitment 2026 - OPEN | CRUK Manchester Institute

We are pleased to announce seven exciting postgraduate opportunities within the Cancer Research UK Manchester Institute for new PhD Students to start in 2026

cruk.manchester.ac.uk

New opportunity - this is a non clinical PhD 4 year program - have a look and DM me if wish to discuss this particular student ship in modelling high risk Leukemia. If that doesn’t take your fancy - there are plenty of exciting projects here!

Cancer Research UK Manchester Institute@cruk-mi.bsky.social · 10mo ago

We have exciting research projects led by group leaders including @jloke1.bsky.social, @giampazolias.bsky.social, @turajliclab.bsky.social, @sylvaindelaunay.bsky.social and @santiagozelenay.bsky.social See full details of all #PhD opportunities here: www.cruk.manchester.ac.uk/phd-student-...

Very excited to join Manchester in the coming months and to continue work from the DFCI! Thanks to the great team here and from Ben for his mentorship and support.

Cancer Research UK Manchester Institute@cruk-mi.bsky.social · 11mo ago

We are delighted to announce, along with The Christie NHS Foundation Trust, the appointment of Dr Justin Loke - @jloke1.bsky.social - to the Amit Patel Leukaemia Research Fellowship, bringing his expertise in haematological research & #AML to our Institute www.cruk.manchester.ac.uk/news/justin-...

Image shows a photograph of Dr Justin Loke, along with a quote: "“I am delighted and privileged to join Manchester with experience of new technologies and scientific training from the Dana-Farber Cancer Institute.”